Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1982 1
1983 2
1985 2
1987 4
1988 4
1989 2
1990 4
1991 4
1992 7
1993 5
1994 3
1995 3
1996 5
1997 7
1998 2
1999 2
2000 5
2002 2
2003 3
2004 3
2005 1
2007 3
2008 2
2009 1
2011 3
2012 5
2013 4
2014 4
2015 1
2016 4
2017 3
2018 4
2019 3
2020 1
2021 5
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Malignant hyperthermia, susceptibility to, 5"
Page 1
Malignant hyperthermia 2020: Guideline from the Association of Anaesthetists.
Hopkins PM, Girard T, Dalay S, Jenkins B, Thacker A, Patteril M, McGrady E. Hopkins PM, et al. Anaesthesia. 2021 May;76(5):655-664. doi: 10.1111/anae.15317. Epub 2021 Jan 5. Anaesthesia. 2021. PMID: 33399225 Free article.
Malignant hyperthermia is defined in the International Classification of Diseases as a progressive life-threatening hyperthermic reaction occurring during general anaesthesia. Malignant hyperthermia has an underlying genetic basis, and genetically s …
Malignant hyperthermia is defined in the International Classification of Diseases as a progressive life-threatening hypertherm …
Malignant hyperthermia.
Rosenberg H, Davis M, James D, Pollock N, Stowell K. Rosenberg H, et al. Orphanet J Rare Dis. 2007 Apr 24;2:21. doi: 10.1186/1750-1172-2-21. Orphanet J Rare Dis. 2007. PMID: 17456235 Free PMC article. Review.
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic gases such as halothane, sevoflurane, desflurane and the depolarizing muscle relaxant succinylcholine, and rarely, i …
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to pot …
Idiopathic hyperCKemia and malignant hyperthermia susceptibility.
Santos JM, Andrade PV, Galleni L, Vainzof M, Sobreira CFR, Schmidt B, Oliveira ASB, Amaral JLG, Silva HCA. Santos JM, et al. Can J Anaesth. 2017 Dec;64(12):1202-1210. doi: 10.1007/s12630-017-0978-x. Epub 2017 Sep 26. Can J Anaesth. 2017. PMID: 28952030 English.
One of the neuromuscular diseases associated with hyperCKemia is malignant hyperthermia (MH). This study investigated the susceptibility to MH in patients with hyperCKemia via in vitro contracture testing (IVCT) and a search of mutations in the RYR1 gene. ... …
One of the neuromuscular diseases associated with hyperCKemia is malignant hyperthermia (MH). This study investigated the s …
Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia.
Beam TA, Loudermilk EF, Kisor DF. Beam TA, et al. Physiol Genomics. 2017 Feb 1;49(2):81-87. doi: 10.1152/physiolgenomics.00126.2016. Epub 2016 Dec 23. Physiol Genomics. 2017. PMID: 28011884 Review.
A review of the pharmacogenetics (PGt) and pathophysiology of calcium voltage-gated channel subunit alpha1 S (CACNA1S) mutations in malignant hyperthermia susceptibility type 5 (MHS5; MIM #60188) is presented. Malignant hyperthermia (MH) …
A review of the pharmacogenetics (PGt) and pathophysiology of calcium voltage-gated channel subunit alpha1 S (CACNA1S) mutations in malig …
Malignant hyperthermia: still an issue for neuromuscular diseases?
De Wel B, Claeys KG. De Wel B, et al. Curr Opin Neurol. 2018 Oct;31(5):628-634. doi: 10.1097/WCO.0000000000000592. Curr Opin Neurol. 2018. PMID: 30015672 Review.
PURPOSE OF REVIEW: We will give an overview of neuromuscular disorders that can be linked with malignant hyperthermia or malignant hyperthermia-like reactions, and suggest an appropriate approach to interpret the risks. ...In contrast, several neuromus …
PURPOSE OF REVIEW: We will give an overview of neuromuscular disorders that can be linked with malignant hyperthermia or ma …
Management of patients susceptible to malignant hyperthermia: A surgeon's perspective.
Carlson KJ, Sun SA, Swan C, Koenig M, Derkay CS. Carlson KJ, et al. Int J Pediatr Otorhinolaryngol. 2022 Aug;159:111187. doi: 10.1016/j.ijporl.2022.111187. Epub 2022 May 30. Int J Pediatr Otorhinolaryngol. 2022. PMID: 35660936
OBJECTIVES: Malignant hyperthermia (MH) susceptibility caries broad implications for the care of pediatric surgical patients. ...No study subjects received muscle biopsy and contracture testing and only 5 (4%) underwent genetic testing for genomic vari …
OBJECTIVES: Malignant hyperthermia (MH) susceptibility caries broad implications for the care of pediatric surgical pat …
Malignant hyperthermia.
Miranda AD, Donovan LA, Schuster LL, Gerber DR. Miranda AD, et al. Am J Crit Care. 1997 Sep;6(5):368-74; quiz 375-6. Am J Crit Care. 1997. PMID: 9283674 Review.
Malignant hyperthermia is a pharmacogenetic disease of skeletal muscle characterized by hypermetabolism that occurs on exposure to a triggering agent or agents. ...This article provides critical care nurses with sound information on the pathophysiology of …
Malignant hyperthermia is a pharmacogenetic disease of skeletal muscle characterized by hypermetabolism that occurs on …
Congenital myopathies: not only a paediatric topic.
Jungbluth H, Voermans NC. Jungbluth H, et al. Curr Opin Neurol. 2016 Oct;29(5):642-50. doi: 10.1097/WCO.0000000000000372. Curr Opin Neurol. 2016. PMID: 27538056 Review.
PURPOSE OF REVIEW: This article reviews adult presentations of the major congenital myopathies - central core disease, multiminicore disease, centronuclear myopathy and nemaline myopathy - with an emphasis on common genetic backgrounds, typical clinicopathological f …
PURPOSE OF REVIEW: This article reviews adult presentations of the major congenital myopathies - central core disease, multiminicore …
Fatigue, depression, and physical activity in patients with malignant hyperthermia: a cross-sectional observational study.
Andrade PMV, Valim LÍM, Santos JMD, Castro I, Amaral JLGD, Silva HCAD. Andrade PMV, et al. Braz J Anesthesiol. 2023 Mar-Apr;73(2):132-137. doi: 10.1016/j.bjane.2021.07.038. Epub 2021 Oct 6. Braz J Anesthesiol. 2023. PMID: 34626754 Free PMC article.
BACKGROUND: Malignant Hyperthermia (MH) is a pharmacogenetic disorder triggered by halogenated anesthesia agents/succinylcholine and characterized by hypermetabolism crisis during anesthesia, but also by day-to-day symptoms, such as exercise intolerance, that may al …
BACKGROUND: Malignant Hyperthermia (MH) is a pharmacogenetic disorder triggered by halogenated anesthesia agents/succinylcholi …
Pre-operative exercise and pyrexia as modifying factors in malignant hyperthermia (MH).
Riazi S, Bersselaar LRVD, Islander G, Heytens L, Snoeck MMJ, Bjorksten A, Gillies R, Dranitsaris G, Hellblom A, Treves S, Kunst G, Voermans NC, Jungbluth H. Riazi S, et al. Neuromuscul Disord. 2022 Aug;32(8):628-634. doi: 10.1016/j.nmd.2022.06.003. Epub 2022 Jun 11. Neuromuscul Disord. 2022. PMID: 35738978 Free article.
Malignant hyperthermia (MH) is a life-threatening reaction triggered by volatile anesthetics and succinylcholine. ...We investigated the role of pre-operative exercise and pyrexia as potential MH modifying factors. We included cases from 5 MH referral centers …
Malignant hyperthermia (MH) is a life-threatening reaction triggered by volatile anesthetics and succinylcholine. ...We invest …
118 results